Dr. Rohini Revansiddappa Pujari

Bio

Dr. Rohini R. Pujari is currently working as an Assistant Professor at Sc earned her PhD from Savitribai Phule Pune University in 2020. She completed her post-graduation from AISSMS College of Pharmacy affiliated with the same university in 2009 and graduation (B. Pharm.) from Bharati Vidyapeeth’s Poona college of Pharmacy, Pune in 2007. Additionally, she received a D. Pharm. from the Institute of Pharmacy, Bharati Vidyapeeth, Pune affiliated with MSBTE and secured the third rank in Maharashtra. With over 16 years of teaching and 10 years of research experience, she has cracked GATE 2007 with an All India Ranking of 209.

Dr. Pujari has been a principal investigator for a research project funded by BCUD, Savitribai Phule Pune University and has received a research grant of 2.2 Lakhs. She has contributed to various research areas such as Neuropharmacology, Alzheimer’s disease, Cerebral ischemia Cancer chemotherapy, Toxicology, Immunopharmacology, Metabolic syndrome and more. She has over 70 review and research publications in several standard national and international journals, including 46 indexed in Scopus and 18 indexed in Web of Science. Furthermore, she has authored 15 book chapters and 04 textbooks. Dr. Pujari has presented her research work at various national and international conferences (40 presentations) and is actively involved in the research activities of her institution.

Dr. Pujari has guided 12 M. Pharm. (Pharmacology) students and currently guiding 3 PhD students. Her current Google Scholar H-index is 14 (I10 index- 16) with 807 citations. Additionally, she is handling the portfolio of overall PhD coordinator of School of Health Sciences and Technology.

Educational Qualifications
M. Pharm, PhD

Research Area

Neuropharmacology, Alzheimer’s disease, Cerebral ischemia Cancer chemotherapy, Toxicology, Immunopharmacology, Metabolic syndrome

Recent Publications

Soni U, Singh K, Jain D, Pujari R. Exploring Alzheimer's disease treatment: Established therapies and novel strategies for future care. Eur J Pharmacol. 2025 Jul 5;998:177520. doi: 10.1016/j.ejphar.2025.177520. Epub 2025 Mar 15. PMID: 40097131.

Phatak M, Nair B, Soni U, Pujari R. Exploring the Gut-brain Axis: Microbiome Contributions to Pathophysiology of Attention Deficit Hyperactivity Disorder and Potential Therapeutic Strategies. Curr Drug Metab. 2025;26(1):1-11. doi: 10.2174/0113892002361676250325082424. PMID: 40207768.

Soni U, Pujari R. Therapeutic Potential of Phytocompounds Gentisic Acid and Alpha Resorcylic Acid against Alzheimer's Disease: A Network Pharmacology, In Silico, and In Vitro Approach. Cell Biochem Biophys. 2025 Nov 10. doi: 10.1007/s12013-025-01944-7. Epub ahead of print. PMID: 41212470.

Gangarde P, Bhatt S, Pujari R. Assessment of neuroprotective potential of Cuscuta reflexa in aluminium chloride-induced experimental model of Alzheimer's disease: In vitro and in vivo studies. J Trace Elem Med Biol. 2025 Apr;88:127612. doi: 10.1016/j.jtemb.2025.127612. Epub 2025 Feb 1. PMID: 39919551.

Pujari RR, Bandawane DD. Hepatoprotective Activity of Gentisic Acid on 5-Fluorouracil-induced Hepatotoxicity in Wistar Rats. Turk J Pharm Sci. 2021 Jun 18;18(3):332-338. doi: 10.4274/tjps.galenos.2020.95870. PMID: 34157823; PMCID: PMC8231324.

Google Scholar Link
https://scholar.google.com/citations?hl=en&user=wsk1XzgAAAAJ&view_op=list_works&sortby=pubdate

Scopus Author ID Link
https://www.scopus.com/authid/detail.uri?authorId=35171051700

Orcid Link
https://orcid.org/0000-0003-4169-6094